Back Source: > 24 October 2009 (E-Business) CV Therapeutics, Inc. - SWOT Analysis CV Therapeutics is a biopharmaceutical company focused on the discovery, development and commercialization of new small molecule drugs for the treatment of cardiovascular diseases.  CV Therapeutics - SWOT Analysis company profile is the essential source for top-level company data and information. CV Therapeutics - SWOT Analysis examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy. CV Therapeutics is a biopharmaceutical company focused on the discovery, development and commercialization of new small molecule drugs for the treatment of cardiovascular diseases. The company applies advances in molecular biology and genetics to identify mechanisms of cardiovascular diseases and targets for drug discovery. CV Therapeutics is headquartered in Palo Alto, California and employed 516 people as of January 2008. The company recorded revenues of $83 million during the financial year (FY) ended December 2007, as compared to revenues of $37 million in FY2006. The significant increase was primarily attributable to the increased market acceptance of Ranexa in the US following its launch in March 2006. The operating loss of the company was $181 million during FY2007, as compared to an operating loss of $278 million in FY2006. The net loss was $181 million in FY2007, as compared to a net loss of $274 million in FY2006. Scope of the Report - Provides all the crucial information on CV Therapeutics required for business and competitor intelligence needs - Contains a study of the major internal and external factors affecting CV Therapeutics in the form of a SWOT analysis as well as a breakdown and examination of leading product revenue streams of CV Therapeutics -Data is supplemented with details on CV Therapeutics history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available statement from CV Therapeutics Reasons to Purchase - Support sales activities by understanding your customers’ businesses better - Qualify prospective partners and suppliers - Keep fully up to date on your competitors’ business structure, strategy and prospects - Obtain the most up to date company information available For more information, please visit : http://www.aarkstore.com/reports/CV-Therapeutics-Inc-SWOT-Analysis-26414.html  Visit